Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$26,552,861
in 2 filings, $26.6M under 10b5-1 plans

Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PATEL DINESH V PH D −$18.2M President and CEO sold 19% of stake
  2. Ali Asif −$8.3M Chief Financial Officer sold 50% of stake
Date Insider Transaction Shares Price Value Owned after
2018-08-15 PATEL DINESH V PH D President and CEO Grant or award · Stock Option (right to buy) +54,700 54,700
2018-08-15 Liu David Y Chief Scientific Officer Grant or award +25,800 40,828
2018-08-15 Liu David Y Chief Scientific Officer Grant or award · Stock Option (right to buy) +17,200 17,200
2018-07-12 PATEL DINESH V PH D President and CEO Gift −2,000 263,779
2018-05-31 Saks Samuel R Chief Development Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2018-05-29 Williams Lewis T Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 Waddill William D. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 Shanafelt Armen Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 SELICK HAROLD E Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 Noonberg Sarah B. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 KHOSLA CHAITAN PHD Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-29 Giraudo Bryan Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-05-17 CANAAN X L.P. 10% owner Sale −38,968 $6.09 $237K 2,116,552
2018-05-16 CANAAN X L.P. 10% owner Sale −29,441 $6.46 $190K 2,155,520
2018-05-15 KHOSLA CHAITAN PHD Director Grant or award · Stock Option (right to buy) +3,000 3,000
2018-05-15 Giraudo Bryan Director Grant or award · Stock Option (right to buy) +24,000 24,000
2018-05-15 CANAAN X L.P. 10% owner Sale −57,715 $6.48 $374K 2,184,961
2018-05-14 CANAAN X L.P. 10% owner Sale −77,591 $6.37 $494K 2,242,676
2018-05-10 PATEL DINESH V PH D President and CEO Option exercise +13,516 $1.16 $16K 265,779
2018-05-10 PATEL DINESH V PH D President and CEO Option exercise · Stock Option (right to buy) −13,516 44,687

Page 23 of 29 · 580 trades